Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzyme Disorder”

769 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 769 results

Not applicableLooking for participantsNCT06749613
What this trial is testing

Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD

Who this might be right for
Irritable Bowel Syndrome
Attikon Hospital 40
Post-approval studies (Phase 4)Looking for participantsNCT02842424
What this trial is testing

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Who this might be right for
Peripheral Arterial Disease
University of Nebraska 70
Not applicableStudy completedNCT00361127
What this trial is testing

Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure

Who this might be right for
Heart Failure, Congestive
Piergiuseppe Agostoni 100
Post-approval studies (Phase 4)Study completedNCT00795912
What this trial is testing

The Usage Of Statins In A Community Heart Failure Population

Who this might be right for
Heart Failure
St Vincent's University Hospital, Ireland 56
Testing effectiveness (Phase 2)Study completedNCT01724931
What this trial is testing

Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Syntrix Biosystems, Inc. 175
Not applicableStudy completedNCT00343577
What this trial is testing

Antiproteinuric Agents and Fabry Disease

Who this might be right for
Fabry DiseaseProteinuria
University of Alabama at Birmingham 12
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Not applicableStudy completedNCT03188601
What this trial is testing

Α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD

Who this might be right for
GVHDBone Marrow Transplant FailureAlpha 1-Antitrypsin
Rambam Health Care Campus 27
Testing effectiveness (Phase 2)WithdrawnNCT01415765
What this trial is testing

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Who this might be right for
Lymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04341402
What this trial is testing

Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study

Who this might be right for
Tinea Unguium, Onychomycosis
William N Handelman 30
Not applicableLooking for participantsNCT06718842
What this trial is testing

Walking Program in Fatty Liver Children With Phenylketonuria

Who this might be right for
PhenylketonuriasNon Alcoholic Fatty Liver
Cairo University 40
Not applicableStudy completedNCT01268241
What this trial is testing

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

Who this might be right for
Fabry DiseaseFabry´s DiseaseAnderson-Fabry Disease
CENTOGENE GmbH Rostock 200
Testing effectiveness (Phase 2)Study completedNCT01506141
What this trial is testing

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment

Who this might be right for
Hunter Syndrome
Takeda 15
Not applicableNot Yet RecruitingNCT06675994
What this trial is testing

In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

Who this might be right for
HealthyHypercholesterolemiaHypertension+6 more
LifeBridge Health 80
Not applicableEnded earlyNCT00873366
What this trial is testing

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 92
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Large-scale testing (Phase 3)Active Not RecruitingNCT05272878
What this trial is testing

Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

Who this might be right for
Acute Kidney Injury
Assistance Publique - Hôpitaux de Paris 508
Large-scale testing (Phase 3)Study completedNCT00880100
What this trial is testing

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
Forest Laboratories 49
Early research (Phase 1)Study completedNCT01894165
What this trial is testing

Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers

Who this might be right for
Molybdenum Cofactor Deficiency (MoCD)Rare Autosomal Recessive DisorderDeficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)
Origin Biosciences 24
Not applicableLooking for participantsNCT06250595
What this trial is testing

European Rare Blood Disorders Platform (ENROL)

Who this might be right for
AnemiaBone Marrow FailureBleeding Disorder+9 more
Hospital Universitari Vall d'Hebron Research Institute 37,090
Load More Results